ERIK D. ROBERSON, M.D.
Neurology at 19 St, Birmingham, AL
License number
Alabama A73759
Category
Neurology
Type
Neurology
License number
Alabama 29140
Category
Neurology
Type
Neurology
Address
Address
619 19Th St S, Birmingham, AL 35249
Phone
(205) 934-4011
(205) 731-9701
(205) 731-9701
Organization information
See more information about ERIK D. ROBERSON at bizstanding.comErik D Roberson MD
1530 3 Ave S, Birmingham, AL 35294
Categories:
Neurology Physicians & Surgeons
Phone:
(205) 934-6737 (Phone)
Erik D Roberson MD
1720 7 Ave STE 640, Birmingham, AL 35294
Categories:
Neurology Physicians & Surgeons
Phone:
(205) 996-3679 (Phone)
Professional information
Associate Professor Of Neurology And Neurobiology At The University Of Alabama At Birmingham
Position:
Associate Professor of Neurology and Neurobiology at The University of Alabama at Birmingham
Location:
Birmingham, Alabama Area
Industry:
Research
Work:
The University of Alabama at Birmingham
since Oct 2012
-
Associate Professor of Neurology and Neurobiology
The University of Alabama at Birmingham
2008 - 2012
-
Assistant Professor of Neurology and Neurobiology
The Gladstone Institutes
2006 - 2008
-
Staff Scientist
UCSF
2002 - 2003
-
Chief Resident in Neurology
Education:
Baylor College of Medicine 1990 - 1999
Ph.D., Neuroscience Baylor College of Medicine 1990 - 1999
M.D. Princeton University 1986 - 1990
A.B., Molecular Biology
Ph.D., Neuroscience Baylor College of Medicine 1990 - 1999
M.D. Princeton University 1986 - 1990
A.B., Molecular Biology
Dr. Erik D Roberson, San Francisco CA - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Neurology)
Address:
UNIVERSITY OF CALIFORNIA SAN FRANCISCO MEDICAL CENTER
400 Parnassus Ave, San Francisco 94143
(415) 353-4624 (Phone), (415) 353-2680 (Fax)
UAB Hospital Neurology
1720 7Th Ave STE 640, Birmingham 35294
(205) 996-3679 (Phone)
400 Parnassus Ave, San Francisco 94143
(415) 353-4624 (Phone), (415) 353-2680 (Fax)
UAB Hospital Neurology
1720 7Th Ave STE 640, Birmingham 35294
(205) 996-3679 (Phone)
Certifications:
Neurology, 2004
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
UNIVERSITY OF CALIFORNIA SAN FRANCISCO MEDICAL CENTER
400 Parnassus Ave, San Francisco 94143
UAB Hospital Neurology
1720 7Th Ave STE 640, Birmingham 35294
UCSF Medical Center
505 Parnassus Ave, San Francisco 94143
UCSF Medical Center at Mount Zion
1600 Divisadero St, San Francisco 94115
400 Parnassus Ave, San Francisco 94143
UAB Hospital Neurology
1720 7Th Ave STE 640, Birmingham 35294
UCSF Medical Center
505 Parnassus Ave, San Francisco 94143
UCSF Medical Center at Mount Zion
1600 Divisadero St, San Francisco 94115
Education:
Medical School
Baylor University
Graduated: 1994
Baylor College Of Med
University Ca Sf School Of Med
Baylor University
Graduated: 1994
Baylor College Of Med
University Ca Sf School Of Med
Erik David Roberson, Birmingham AL
Specialties:
Neurology, Neurological Surgery
Work:
The Kirklin Clinic Uab
2000 6Th Ave S, Birmingham, AL 35233
2000 6Th Ave S, Birmingham, AL 35233
Education:
Baylor College of Medicine (1999), UCSF Medical Centers (2005) *Neurology
Method Of Increasing Cathepsin B-Induced Cleavage Of Amyloid-Β Peptides
US Patent:
8388953, Mar 5, 2013
Filed:
Jun 29, 2010
Appl. No.:
12/826403
Inventors:
Li Gan - Burlingame CA, US
Lennart Mucke - San Francisco CA, US
Erik Roberson - Vestavia Hills AL, US
Sarah Mueller-Steiner - Uitikon Waldegg, CH
Lennart Mucke - San Francisco CA, US
Erik Roberson - Vestavia Hills AL, US
Sarah Mueller-Steiner - Uitikon Waldegg, CH
Assignee:
The J. David Gladstone Institutes - San Francisco CA
International Classification:
A61K 38/43
US Classification:
424 9463, 424 94, 530350
Abstract:
The present invention provides a method of increasing cathepsin B-induced cleavage of amyloid-β (Aβ) peptide in a cell or tissue, the method generally involving contacting the cell or tissue with an agent that increases the level of cathepsin B in the cell or tissue. The present invention further provides variant cathepsin B polypeptides that are resistant to inhibition by a cysteine protease inhibitor; as well as nucleic acids encoding the variants, and host cells comprising the nucleic acids.
Agents That Reduce Neuronal Overexcitation
US Patent:
2012019, Aug 2, 2012
Filed:
Apr 7, 2011
Appl. No.:
13/082170
Inventors:
ERIK ROBERSON - Vestavia Hills AL, US
Lennart Mucke - San Francisco CA, US
Lennart Mucke - San Francisco CA, US
International Classification:
G01N 33/53, C12Q 1/68, G01N 33/577
US Classification:
800 3, 435 792, 435 71, 436501, 435 61
Abstract:
The present invention provides methods of identifying candidate agents for treating excitotoxicity-related disorders. The present invention further provides methods for treating excitotoxicity-related disorders.